<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 15 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
h1
{mso-style-priority:9;
mso-style-link:"Heading 1 Char";
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:24.0pt;
font-family:"Calibri",sans-serif;
font-weight:bold;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
span.Heading1Char
{mso-style-name:"Heading 1 Char";
mso-style-priority:9;
mso-style-link:"Heading 1";
font-family:"Calibri Light",sans-serif;
color:#2F5496;}
p.speakabletextp1, li.speakabletextp1, div.speakabletextp1
{mso-style-name:speakabletextp1;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
p.speakabletextp2, li.speakabletextp2, div.speakabletextp2
{mso-style-name:speakabletextp2;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.link
{mso-style-name:link;}
p.wellness-disclosure, li.wellness-disclosure, div.wellness-disclosure
{mso-style-name:wellness-disclosure;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.EmailStyle25
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-US link=blue vlink=purple style='word-wrap:break-word'><div class=WordSection1><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p><div><div style='border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in'><p class=MsoNormal><b>From:</b> tech-vi@groups.io <tech-vi@groups.io> <b>On Behalf Of </b>David Goldfield<br><b>Sent:</b> Tuesday, March 7, 2023 8:39 PM<br><b>To:</b> List <tech-vi@groups.io><br><b>Subject:</b> [tech-vi Announce List] Eye Drops Sold Worldwide Recalled Due to Non-Sterility - CNET<o:p></o:p></p></div></div><p class=MsoNormal><o:p> </o:p></p><div><p>CNET - Tuesday, March 7, 2023 at 2:02 PM<o:p></o:p></p><h1>Eye Drops Sold Worldwide Recalled Due to Non-Sterility - CNET<o:p></o:p></h1><p class=speakabletextp1>Pharmedica USA is recalling two lots of Purely Soothing 15% MSM Drops eye drops that were sold worldwide at online retailers including Amazon. Using the drops could pose a "risk of eye infections that could result in blindness," according to a <a href="https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pharmedica-usa-llc-issues-voluntary-worldwide-recall-purely-soothing-15-msm-drops-due-non-sterility" target="_blank">notice</a> posted last week by the US Food and Drug Administration.<o:p></o:p></p><p class=speakabletextp2>Citing concerns about "non-sterility," Pharmedica USA said people who bought the eye drops should immediately stop using them and return them to the place of purchase.<o:p></o:p></p><p>The recalled products are 30 milliliter and 15 milliliter white, cylindrical HDPE eye drop bottles with UPC numbers 731034913799 and 731034913829. Look for bottles with lot codes 2203PS01 and 1808051 on the label. <o:p></o:p></p><p>So far, the FDA post said, there aren't any reported illnesses or injuries in connection with this recall. The notice said customers should contact their health care provider if they experience any symptoms after using the potentially contaminated eye drops. <o:p></o:p></p><p>This is the latest in a series of eye drop recalls this year. Last week, the FDA posted a <a href="https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/apotex-corp-issues-voluntary-nationwide-recall-brimonidine-tartrate-ophthalmic-solution-015-due" target="_blank">recall alert</a> about six lots of Brimonidine Tartrate Ophthalmic Solution, 0.15% from Apotex Corporation, after reports of cracks developing in the bottles' caps. There was concern about the sterility of the product. <o:p></o:p></p><p>On Feb. 24, the FDA posted <a href="https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/global-pharma-healthcare-issues-voluntary-nationwide-recall-delsam-pharma-artificial-eye-ointment" target="_blank">a notice</a> about Global Pharma Healthcare recalling Artificial Eye Ointment distributed by Delsam Pharma. The product was reported to be leaking, and there were concerns about contamination that could lead to eye infection and blindness. <o:p></o:p></p><p>Before that, <span class=link><a href="https://www.cnet.com/health/medical/some-artificial-tears-recalled-over-infection-risk/">Global Pharma recalled</a></span> all lots of its <a href="https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/global-pharma-healthcare-issues-voluntary-nationwide-recall-artificial-tears-lubricant-eye-drops-due" target="_blank">Artificial Tears Lubricant Eye Drops</a> distributed by EzriCare and Delsam Pharma. The drops had been linked to 55 cases of eye infection in 12 states, including cases that led to vision loss, hospitalization and one death. <o:p></o:p></p><p class=wellness-disclosure><em><span style='font-family:"Calibri",sans-serif'>The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.</span></em> <o:p></o:p></p><p><a href="https://www.cnet.com/health/medical/eye-drops-sold-worldwide-recalled-due-to-non-sterility/#ftag=CAD590a51e">https://www.cnet.com/health/medical/eye-drops-sold-worldwide-recalled-due-to-non-sterility/#ftag=CAD590a51e</a><o:p></o:p></p></div><p class=MsoNormal style='margin-bottom:12.0pt'><o:p> </o:p></p><div><p class=MsoNormal> David Goldfield <o:p></o:p></p><div><p class=MsoNormal>Assistive Technology Specialist<o:p></o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal>Subscribe to the Tech-VI announcement list to receive news and updates regarding the blindness assistive technology space<br><span style='font-size:17.0pt'>Email: Tech-VI+subscribe@groups.io</span><o:p></o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal>WWW.DavidGoldfield.com<o:p></o:p></p></div></div><div><p class=MsoNormal><span style='color:white'>_._,_._,_<o:p></o:p></span></p></div><div class=MsoNormal align=center style='text-align:center'><hr size=2 width="100%" align=center></div><p class=MsoNormal>Groups.io Links:<o:p></o:p></p><p>You receive all messages sent to this group. <o:p></o:p></p><p><a href="https://groups.io/g/tech-vi/message/3587" target="_blank">View/Reply Online (#3587)</a> | <a href="mailto:tech-vi@groups.io?subject=Re:%20%5Btech-vi%20Announce%20List%5D%20Eye%20Drops%20Sold%20Worldwide%20Recalled%20Due%20to%20Non-Sterility%20-%20CNET" target="_blank">Reply To Group</a> | <a href="mailto:david.goldfield@outlook.com?subject=Private:%20Re:%20%5Btech-vi%20Announce%20List%5D%20Eye%20Drops%20Sold%20Worldwide%20Recalled%20Due%20to%20Non-Sterility%20-%20CNET" target="_blank">Reply To Sender</a> | <a href="https://groups.io/mt/97464341/17455" target="_blank">Mute This Topic</a> | <a href="https://groups.io/g/tech-vi/post">New Topic</a><br><a href="https://groups.io/g/tech-vi/editsub/17455">Your Subscription</a> | <a href="mailto:tech-vi+owner@groups.io">Contact Group Owner</a> | <a href="https://groups.io/g/tech-vi/leave/8954496/17455/1106850279/xyzzy">Unsubscribe</a> [terrypowers59@gmail.com]<o:p></o:p></p><div><p class=MsoNormal><span style='color:white'>_._,_._,_<o:p></o:p></span></p></div></div></body></html>